Pancreatic cancer

Immunotherapy combined with chemotherapy in the study increased median survival for metastatic pancreatic cancer to 14.3 months.

CompilationThe results of pancreatic cancer treatment are usually not very encouraging for the scientific community; the tumor microenvironment of these…

5 months ago

Strategy that allows pancreatic cancer to ‘outsmart’ defenses

After decades of wanting to understand how they achieve this, Spanish research teams are now revealing their strategy: pancreatic cancer…

6 months ago

Liquid biopsy for the study of stomach and pancreatic tumors

CompilationPangea Lab researchers have introduced a new way to use liquid biopsy other than bloodits dual purpose, which consists of…

7 months ago

WHO warns there will be 35 million new cancer cases in 2050, up 77% from 2022

The number of cancer cases is increasing around the world, but not all countries have sufficient resources to prevent, treat…

10 months ago